Park Medi World
Park Medi World Q1 FY27: Capex ₹767 Cr
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
Park Medi World expects a revenue growth of 24% for FY’27, targeting Rs. For FY'27, Park Medi World expects: - Revenue growth of 24% to Rs.
From Park Medi World's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Park Medi World expects a revenue growth of 24% for FY’27, targeting Rs. 2,080 crores in revenue.
- EBITDA is projected to grow by 25%, reaching Rs. 530 crores, and PAT is expected to grow by 32% to Rs. 360 crores.
- ARPOB (Average Revenue Per Occupied Bed) growth guidance is 10%-12% annually for the next two years, driven by a shift toward advanced super-specialty treatments and inflation.
- Bed capacity is planned to reach 4,740 by end of FY’27 and 5,740 by end of FY’28, with ongoing ramp-up in new facilities like Rudrapur and Panchkula.
2 more points from Park Medi World's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Park Medi World said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Ongoing CAPEX and acquisition spend primarily focused on Rudrapur acquisition, Narela commissioning, and equipment upgrades across the network.
- CAPEX per bed remains low at Rs.37 lakhs, the lowest among listed healthcare peers.
- Total planned CAPEX for FY’27 and FY’28 is Rs.767 crores to add 2,130 beds, maintaining a blended CAPEX per bed of Rs.36 lakhs (includes acquisitions).
- Additional CAPEX on Rudrapur expected to be around Rs.10-12 crores for equipment replacement and additions.
- Adding 450 beds in Q3 FY’27, including 100 beds at Palam Vihar and 150 beds in Zirakpur.
- Plan to increase total bed capacity to 4,740 by end FY’27 and to 5,740 by end FY’28.
2 more points from Park Medi World's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Park Medi World said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- There is no explicit mention of a current or expected order book or pending orders in the provided transcript.
- The company focuses on bed capacity additions as part of its growth plan, with 1,490 beds added in calendar year 2026 and an expected total capacity of 4,740 beds by the end of FY’27, then reaching 5,740 beds by FY’28.
- Acquisitions and extensions include the Rudrapur acquisition, Palam Vihar expansion, and a new acquisition in Zirakpur, totaling 450 beds for commissioning in late 2026.
2 more points from Park Medi World's call on order book
Pro opens every point from 15K+ earnings calls
Park Medi World — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹77 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Park Medi World Ltd's management said in earlier quarters
Others in Healthcare Services this season
- KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio DX Ltd (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
- Krsnaa Diagnostics Ltd (Q1 FY27)
. Key concall takeaways from Krsnaa Diagnost.'s Q1 FY27 earnings call — and how it ranks against sector peers.
- Artemis Medicare Services Ltd (Q1 FY27)
Potential to reach INR 2,000 crores topline from Gurgaon alone within 3-5 years. Key concall takeaways from Artemis Medicare Services Ltd's Q1 FY27 earnings…
Arthneeti Pro · Annual
Park Medi World and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Park Medi World Q1 FY27 results?
Park Medi World expects a revenue growth of 24% for FY’27, targeting Rs. For FY'27, Park Medi World expects: - Revenue growth of 24% to Rs.
What is Park Medi World share price analysis?
Park Medi World currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 42.7 with a market cap of ₹11,859 Cr. Investors should review the full earnings analysis for detailed insights.
Is Park Medi World planning capital expenditure?
Ongoing CAPEX and acquisition spend primarily focused on Rudrapur acquisition, Narela commissioning, and equipment upgrades across the network.
Keep Park Medi World on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.